Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06144554 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv5
  2. Completion date: Sep 2027 to Sep 2028v4
  3. Primary completion date: Sep 25, 2025 to Jun 2027 Completion date: Jan 28, 2026 to Sep 2027v3 Show 1 more changeShow less
    • Completion date: Jan 28, 2026 to Sep 2027
  4. Re-verified, no change to tracked fieldsv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Insulet Corporation
11 trials monitored
See 1 trial at risk
Diabetes
4,286 trials monitored
See 187 trials at risk
Type 1 Diabetes
853 trials monitored
See 38 trials at risk
This is a decentralized observational clinical registry to collect real-world evidence related to the safety and effectiveness of the Omnipod 5 system in children and adults with Type 1 Diabetes.
Trial Details
NCT Number NCT06144554
Lead Sponsor Insulet Corporation
Conditions Type 1 Diabetes
Enrollment 2,200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov